The global attenuated vaccines market is expected to expand from US$ 4.45 billion in 2022 to US$ 9.31 billion by 2032 at a compound annual growth rate (CAGR) of 6.8%.Attenuated vaccination helps in preventing ailments like yellow fever, tuberculosis, measles, retroviral, and likewise. Moreover, it has been reported.
Through a recent series of scientific symposia, more than 1,800 health care professionals nationwide both online and on site have had a chance to learn the latest scientific advances in the management and prevention of pneumococcal diseases to have more comprehensive insights and give patients the most up-to-date and accurate medical advice.